This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wu, H. Articles by Curiel, D. T. Search for Related Content PubMed PubMed Citation Articles by Wu, H. Articles by Curiel, D. T.

 Previous Article  |  Next Article 

Journal of Virology, March 2005, p. 3382-3390, Vol. 79, No. 6
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.6.3382-3390.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Identification of Sites in Adenovirus Hexon for Foreign Peptide Incorporation

Hongju Wu, Tie Han, Natalya Belousova, Victor Krasnykh, Elena Kashentseva, Igor Dmitriev, Manjula Kataram, Parameshwar J. Mahasreshti, and David T. Curiel^*

Division of Human Gene Therapy, Departments of Medicine, Pathology and Surgery, and the Gene Therapy Center, University of Alabama at Birmingham, Birmingham, Alabama

Received 9 April 2004/ Accepted 1 November 2004

Adenovirus type 5 (Ad5) is one of the most promising vectors for gene therapy applications. Genetic engineering of Ad5 capsid proteins has been employed to redirect vector tropism, to enhance infectivity, or to circumvent preexisting host immunity. As the most abundant capsid protein, hexon modification is particularly attractive. However, genetic modification of hexon often results in failure of rescuing viable viruses. Since hypervariable regions (HVRs) are nonconserved among hexons of different serotypes, we investigated whether the HVRs could be used for genetic modification of hexon by incorporating oligonucleotides encoding six histidine residues (His₆) into different HVRs in the Ad5 genome. The modified viruses were successfully rescued, and the yields of viral production were similar to that of unmodified Ad5. A thermostability assay suggested the modified viruses were stable. The His₆ epitopes were expressed in all modified hexon proteins as assessed by Western blotting assay, although the intensity of the reactive bands varied. In addition, we examined the binding activity of anti-His tag antibody to the intact virions with the enzyme-linked immunosorbent assay and found the His₆ epitopes incorporated in HVR2 and HVR5 could bind to anti-His tag antibody. This suggested the His₆ epitopes in HVR2 and HVR5 were exposed on virion surfaces. Finally, we examined the infectivities of the modified Ad vectors. The His₆ epitopes did not affect the native infectivity of Ad5 vectors. In addition, the His₆ epitopes did not appear to mediate His₆-dependent viral infection, as assessed in two His₆ artificial receptor systems. Our study provided valuable information for studies involving hexon modification.

Present address: Experimental Diagnostic Imaging, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030.

This article has been cited by other articles:

• McConnell, M. J., Danthinne, X., Imperiale, M. J. (2006). Characterization of a permissive epitope insertion site in adenovirus hexon.. J. Virol. 80: 5361-5370 [Abstract] [Full Text]  
• Krause, A., Joh, J. H., Hackett, N. R., Roelvink, P. W., Bruder, J. T., Wickham, T. J., Kovesdi, I., Crystal, R. G., Worgall, S. (2006). Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunity.. J. Virol. 80: 5523-5530 [Abstract] [Full Text]  
• Vellinga, J., Van der Heijdt, S., Hoeben, R. C. (2005). The adenovirus capsid: major progress in minor proteins. J. Gen. Virol. 86: 1581-1588 [Abstract] [Full Text]